e-learning
resources
Munich 2014
Sunday, 07.09.2014
Interventions and other therapeutic approaches in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Immunoglobulin G subclass deficiency in adult patients with chronic obstructive lung diseases
J. H. Kim, S. Park, Y. I. Hwang, S. H. Jang, K. S. Jung, Y. S. Sim, T. R. Shin, S. M. Park, D. G. Kim (Anyang, Seoul, Republic Of Korea)
Source:
International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Session:
Interventions and other therapeutic approaches in respiratory infections
Session type:
Poster Discussion
Number:
242
Disease area:
Airway diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. H. Kim, S. Park, Y. I. Hwang, S. H. Jang, K. S. Jung, Y. S. Sim, T. R. Shin, S. M. Park, D. G. Kim (Anyang, Seoul, Republic Of Korea). Immunoglobulin G subclass deficiency in adult patients with chronic obstructive lung diseases. Eur Respir J 2014; 44: Suppl. 58, 242
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Expert interview: TB-Machine learning and artificial intelligence as allies in clinical decision
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
Treatment and prevention of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Viral infections
Year: 2013
Clinical relevance of respiratory pathogens in patients hospitalised with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Interesting cases of respiratory infections
Year: 2013
Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014
Interferon inducer in treatment of acute respiratory viral infections in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Antibiotics, antifungals and other therapeutic options
Year: 2014
Pulmonary nocardiosis (PN) complicating chronic pulmonary diseases
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Etiologies of exacerbations of the chronic obstructive pulmonary disease in Tunisia
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
Respiratory viral infections in patients with exacerbation of chronic obstructive pulmonary disease and asthma in Korea
Source: Eur Respir J 2005; 26: Suppl. 49, 285s
Year: 2005
Identification of nasal virus infection in patients with COPD exacerbations
Source: International Congress 2014 – COPD: points to ponder
Year: 2014
Viral infections as a cause of chronic obstructive pulmonary disease (COPD) exacerbations
Source: Annual Congress 2009 - Exacerbations of COPD: new findings
Year: 2009
Etiological structure from sputum of patients with exacerbation of COPD
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014
Should chronic obstructive pulmonary disease patients must be vaccinated?
Source: Annual Congress 2013 –Lung infections: a clinical point of view
Year: 2013
IgG immunoglobulin levels and the frequency of respiratory infections in patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 543s
Year: 2002
Respiratory viral infections in Iranian patients with exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas
Year: 2010
Relationship between procacitonin and C-reactive protein and sputum culture results in patients with acute excecerbation of COPD
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014
Etiology of exacerbations in severe COPD patients with bronchial chronic colonization by pseudomonas
Source: Annual Congress 2013 –Difficult and rare respiratory infections
Year: 2013
Acute exacerbations of chronic obstructive pulmonary disease: Is it acute exacerbations of chronic cardiopulmonary disease?
Source: International Congress 2014 – Comorbidities
Year: 2014
Localization of respiratory viral antigens in patients with exacerbations of non allergic late-onset asthma and chronic obstructive pulmonary disease
Source: Eur Respir J 2004; 24: Suppl. 48, 411s
Year: 2004
Prevalence of exacerbation in COPD patients with chronic bronchitis and association with elevated serum inflammatory biomarkers
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Exacerbations in patients with chronic obstructive lung disease (COPD) and concomitant asthma
Source: International Congress 2014 – Asthma or COPD: comorbid condition or a poorly understood single disease?
Year: 2014
Inflammatory biomarkers and exacerbations in chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept